Figure 1From: Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil Diagram for patients chronically infected with hepatitis C virus: Diagrams of transition for treatment of chronic infection with hepatitis C virus in mutually excluding stages. Back to article page